Pulse Health Limited shares rocket, is it time to buy this growth share?

Pulse Health Limited (ASX:PHG) reports a strong full year result. Could it be one of the best growth shares on the ASX?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

When it comes to private hospital operators most investors will be well aware of industry giants Ramsay Health Care Limited (ASX: RHC) and Healthscope Ltd (ASX: HSO).

But there is a smaller player amongst the ranks that I feel investors should be taking note of and that is Pulse Health Limited (ASX: PHG).

This morning the private hospital operator reported a strong full year result which initially had its share price rocketing higher by 10%. Its shares have since come down a touch and finished the day higher by just over 5%.

For FY 2016 Pulse Health reported revenue growth of 29% to $72.4 million, with an impressive 23% of this growth coming from established hospitals and day surgeries.

Underlying earnings before interest, tax, depreciation, and amortisation (EBITDA) came in 38% higher at $9.1 million after excluding one off items and its greenfield ramp up. This meant underlying EBITDA came in at the top end of the guidance management provided in May of between $8 million and $9.2 million.

On the bottom line the company reported a loss of $3.9 million, compared to a $2.5 million profit last year. This was largely the result of acquisition, development, and integration costs related to the acquisition of Zenitas Holdings Pty Ltd and Boulcott Hospital, as well as the unsuccessful acquisition of Vision Eye Limited. Excluding significant and one-time items meant net profit after tax was 13.5% higher at $4.6 million.

Overall I feel this was a solid result if you look beyond the one-time items. The 38% jump in EBITDA is fantastic, but perhaps even better is the fact that the company has forecast FY 2017 underlying EBITDA from established hospitals in the range of $13.5 million to $15.5 million.

This implies stunning annual EBITDA growth of 48% to 70% which I believe could make Pulse Health a great investment this week. Especially considering its shares are trading on an EV/EBITDA ratio of just over 9x. This is a big discount to both Ramsay and Healthscope which have been trading on EV/EBITDA ratios of around 15x recently.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »